Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 1
1971 1
1975 1
1977 1
1978 3
1979 5
1981 2
1982 5
1983 4
1984 4
1985 2
1986 3
1987 5
1988 2
1989 5
1990 1
1991 1
1992 1
1993 3
1994 6
1995 4
1996 10
1997 7
1998 4
1999 11
2000 5
2001 9
2002 6
2003 8
2004 9
2005 7
2006 9
2007 14
2008 11
2009 13
2010 19
2011 23
2012 17
2013 16
2014 16
2015 21
2016 16
2017 9
2018 7
2019 5
2020 5
2021 3
2022 3
2023 2
2024 3
2025 4
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

319 results

Results by year

Filters applied: . Clear all
Page 1
Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.
Holida M, Linhart A, Longo N, Wallace E, Tøndel C, Hughes D, Warnock DG, Pisani A, Eyskens F, Deegan P, Feldt-Rasmussen U, Goker-Alpan O, Mehta A, Piotti G, Fichera V, Wang M, Chertkoff R, Waldek S, Wilcox WR, Bernat JA. Holida M, et al. Among authors: warnock dg. Orphanet J Rare Dis. 2026 Mar 20;21(1):185. doi: 10.1186/s13023-026-04303-8. Orphanet J Rare Dis. 2026. PMID: 41862950 Free PMC article. Clinical Trial.
Impact of Proteinuria on Renal Outcomes in the BALANCE Trial.
Wallace EL, Wanner C, Piotti G, Lee D, Koulinska I, Chertkoff R, Warnock DG; BALANCE Study Group. Wallace EL, et al. Among authors: warnock dg. Kidney Int Rep. 2025 Nov 19;11(2):103691. doi: 10.1016/j.ekir.2025.11.016. eCollection 2026 Feb. Kidney Int Rep. 2025. PMID: 41531439 Free PMC article. No abstract available.
Expanded View of the Pathophysiology of Fabry Disease.
Kmoch S, Živná M, Dvela-Levitt M, Braun F, Rozenfeld P, Wanner C, Hughes D, Schiffmann R, Warnock DG. Kmoch S, et al. Among authors: warnock dg. Nephron. 2025;149(10):620-624. doi: 10.1159/000546555. Epub 2025 Jun 30. Nephron. 2025. PMID: 40587960 No abstract available.
A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.
Holida M, Linhart A, Pisani A, Longo N, Eyskens F, Goker-Alpan O, Wallace E, Deegan P, Tøndel C, Feldt-Rasmussen U, Hughes D, Sakov A, Rocco R, Almon EB, Alon S, Chertkoff R, Warnock DG, Waldek S, Wilcox WR, Bernat JA. Holida M, et al. Among authors: warnock dg. J Inherit Metab Dis. 2025 Jan;48(1):e12795. doi: 10.1002/jimd.12795. Epub 2024 Oct 9. J Inherit Metab Dis. 2025. PMID: 39381863 Free PMC article. Clinical Trial.
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.
Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhart A, Hughes DA, Hopkin RJ, Tøndel C, Langeveld M, Giraldo P, Pisani A, Germain DP, Mehta A, Deegan PB, Molnar MJ, Ortiz D, Jovanovic A, Muriello M, Barshop BA, Kimonis V, Vujkovac B, Nowak A, Geberhiwot T, Kantola I, Knoll J, Waldek S, Nedd K, Karaa A, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Sakov A, Warnock DG. Wallace EL, et al. Among authors: warnock dg. J Med Genet. 2024 May 21;61(6):520-530. doi: 10.1136/jmg-2023-109445. J Med Genet. 2024. PMID: 37940383 Free PMC article. Clinical Trial.
Risk Factors for Incident CKD in Black and White Americans: The REGARDS Study.
Cheung KL, Crews DC, Cushman M, Yuan Y, Wilkinson K, Long DL, Judd SE, Shlipak MG, Ix JH, Bullen AL, Warnock DG, Gutiérrez OM. Cheung KL, et al. Among authors: warnock dg. Am J Kidney Dis. 2023 Jul;82(1):11-21.e1. doi: 10.1053/j.ajkd.2022.11.015. Epub 2023 Jan 6. Am J Kidney Dis. 2023. PMID: 36621640 Free PMC article.
319 results